RIL
TARA icon

Rothschild Investment LLC’s Protara Therapeutics TARA Stock Holding History

Rothschild Investment LLC’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195 Buy
51
+8
+19% +$38 ﹤0.01% 3440
2026
Q1 		$224 Buy
43
+42
+4,200% +$249 ﹤0.01% 3285
2025
Q4 		$5 Buy
+1
New +$6 ﹤0.01% 3403

Other funds holding TARA

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Rothschild Investment LLC's TARA Position: Q2 2026 in Review

Rothschild Investment LLC increased its Protara Therapeutics (TARA) stake by 19% in Q2 2026, buying an estimated $38 and bringing the position to 51 shares worth $195. The position accounts for ﹤0.01% of the portfolio, ranked #3440.

Rothschild Investment LLC first reported a position in TARA in Q4 2025 and has held it in 3 quarters since. The position peaked at $224 in Q1 2026. 26 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Rothschild Investment LLC held 51 shares of Protara Therapeutics worth $195 as of Q2 2026.
  • Rothschild Investment LLC bought 8 Protara Therapeutics shares in Q2 2026, an estimated $38.
  • Protara Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3440 holding.
  • Rothschild Investment LLC first reported a position in Protara Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Rothschild Investment LLC's Protara Therapeutics position peaked at $224 in Q1 2026.
  • 26 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.